Biohaven's Nurtec® ODT Extends Partnership with Rick Ware Racing for 2022 NASCAR Cup Series and NTT INDYCAR Series

/PRNewswire/ -- Biohaven Pharmaceuticals (NYSE:BHVN) announced today that Nurtec® ODT (rimegepant) extends its sponsorship for the second year as the primary...

Related Keywords

Pearl Harbor ,Hawaii ,United States ,North Carolina ,America ,Kate Fegley ,Greg Peterman ,Takuma Sato ,Mike Beyer ,Biohaven Neuroinnovation ,Centers For Disease ,Exchange Commission On ,Twitter ,World Health Organization ,Drug Administration ,Sam Brown Inc ,Biohaven Supports Military Salutes Program ,Biohaven Pharmaceutical Holding Company Ltd ,Salutes Program ,Board Of Biohaven Pharmaceuticals ,Company Quarterly Report On Form ,Asian Le Mans Series ,Road America ,Rick Ware ,Rick Ware Racing ,Chief Executive Officer ,Biohaven Pharmaceuticals ,Military Salutes ,Nine Line ,Ware Racing ,Biohaven Supports Military Salutes ,Military Salutes Program ,Disease Control ,Green Beret ,Prescribing Information ,Private Securities Litigation Reform Act ,Annual Report ,Exchange Commission ,Quarterly Report ,Biohaven Pharmaceutical Ireland ,Biohaven Pharmaceutical Holding Company ,Executive Officer ,Ware Racing Contact ,Pharmaceutical Holding Company ,